Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1988 Nov;64(757):871–874. doi: 10.1136/pgmj.64.757.871

Retinal pigment epithelial change and partial lipodystrophy.

T M Davis 1, D R Holdright 1, W E Schulenberg 1, R C Turner 1, G F Joplin 1
PMCID: PMC2429063  PMID: 3255937

Abstract

Cuticular drusen and retinal pigment epithelial changes were found incidentally in a 27 year old Lebanese woman during assessment of partial lipodystrophy. Her vision was normal despite involvement of both maculae. The patient had hypocomplementaemia, but serum C3 nephritic factor was absent and renal function was normal. She had impaired glucose tolerance and a continuous infusion of glucose with model assessment (CIGMA) test revealed low normal tissue insulin sensitivity and high normal pancreatic beta cell function. Mild fasting hypertriglyceridaemia (2.0 mmol/l) may have been secondary to impaired insulin sensitivity. Endocrine function was otherwise normal apart from a completely absent growth hormone response to adequate hypoglycaemia. The simultaneous occurrence of partial lipodystrophy and retinal pigmentary epithelial and basement membrane changes appears to be a newly recognized syndrome.

Full text

PDF
871

Images in this article

872Figure 1
on p.872
872Figure 2
on p.872

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett W. M., Bardana E. J., Wuepper K., Houghton D., Border W. A., Götze O., Schreiber R. Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis. Am J Med. 1977 May;62(5):757–760. doi: 10.1016/0002-9343(77)90879-8. [DOI] [PubMed] [Google Scholar]
  2. Burn J., Baraitser M. Partial lipoatrophy with insulin resistant diabetes and hyperlipidaemia (Dunnigan syndrome). J Med Genet. 1986 Apr;23(2):128–130. doi: 10.1136/jmg.23.2.128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Crome P., Keen H. Partial lipodystrophy and insulin-resistant diabetes. Diabete Metab. 1978 Jun;4(2):81–84. [PubMed] [Google Scholar]
  4. Davidson M. B., Young R. T. Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities. Diabetologia. 1975 Dec;11(6):561–568. doi: 10.1007/BF01222107. [DOI] [PubMed] [Google Scholar]
  5. Dunnigan M. G., Cochrane M. A., Kelly A., Scott J. W. Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q J Med. 1974 Jan;43(169):33–48. [PubMed] [Google Scholar]
  6. Gibbons G. F., Pullinger C. R., Björnsson O. G. Changes in the sensitivity of lipogenesis in rat hepatocytes to hormones and precursors over the diurnal cycle and during longer-term starvation of donor animals. J Lipid Res. 1984 Dec 1;25(12):1358–1367. [PubMed] [Google Scholar]
  7. Goldberg R. B. Lipid disorders in diabetes. Diabetes Care. 1981 Sep-Oct;4(5):561–572. doi: 10.2337/diacare.4.5.561. [DOI] [PubMed] [Google Scholar]
  8. Hosker J. P., Matthews D. R., Rudenski A. S., Burnett M. A., Darling P., Bown E. G., Turner R. C. Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia. 1985 Jul;28(7):401–411. doi: 10.1007/BF00280882. [DOI] [PubMed] [Google Scholar]
  9. Köbberling J., Willms B., Kattermann R., Creutzfeldt W. Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik. 1975 Sep 10;29(2):111–120. doi: 10.1007/BF00430347. [DOI] [PubMed] [Google Scholar]
  10. O'Rahilly S., Spivey R. S., Holman R. R., Nugent Z., Clark A., Turner R. C. Type II diabetes of early onset: a distinct clinical and genetic syndrome? Br Med J (Clin Res Ed) 1987 Apr 11;294(6577):923–928. doi: 10.1136/bmj.294.6577.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Peters D. K., Charlesworth J. A., Sissons J. G., Williams D. G., Boulton-Jones J. M., Evans D. J., Kourilsky O., Morel-Maroger L. Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet. 1973 Sep 8;2(7828):535–538. doi: 10.1016/s0140-6736(73)92351-9. [DOI] [PubMed] [Google Scholar]
  12. Piscatelli R. L., Vieweg W. V., Havel R. J. Partial lipodystrophy. Metabolic studies in three patients. Ann Intern Med. 1970 Dec;73(6):963–970. doi: 10.7326/0003-4819-73-6-963. [DOI] [PubMed] [Google Scholar]
  13. Richards N. T., Wood S. M., Christofides N. D., Bhuttacharji S. C., Bloom S. R. Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF(1-44)] in type 2 (non-insulin-dependent) diabetes. Diabetologia. 1984 Nov;27(5):529–534. doi: 10.1007/BF00290390. [DOI] [PubMed] [Google Scholar]
  14. Rifkind B. M., Boyle J. A., Gale M. Blood lipid levels, thyroid status, and glucose tolerance in progressive partial lipodystrophy. J Clin Pathol. 1967 Jan;20(1):52–55. doi: 10.1136/jcp.20.1.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. SENIOR B., GELLIS S. S. THE SYNDROMES OF TOTAL LIPODYSTROPHY AND OF PARTIAL LIPODYSTROPHY. Pediatrics. 1964 Apr;33:593–612. [PubMed] [Google Scholar]
  16. Tzagournis M., George J., Herrold J. Increased growth hormone in partial and total lipoatrophy. Diabetes. 1973 May;22(5):388–396. doi: 10.2337/diab.22.5.388. [DOI] [PubMed] [Google Scholar]
  17. Williams T., Berelowitz M., Joffe S. N., Thorner M. O., Rivier J., Vale W., Frohman L. A. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med. 1984 Nov 29;311(22):1403–1407. doi: 10.1056/NEJM198411293112203. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES